E.E. Geduld’s Grace Therapeutics GRCE Stock Holding History

E.E. Geduld’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-52	Closed	-$31K	–	345
2013 Q4	$31K	Buy	+52	New	+$42.6K	0.02%	278

Other funds holding GRCE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

E.E. Geduld's GRCE Position: Q1 2014 in Review

E.E. Geduld sold out of Grace Therapeutics (GRCE) in Q1 2014, closing a stake of 52 shares — an estimated $31K sold.

E.E. Geduld first reported a position in GRCE in Q4 2013 and held it in 1 quarter. The position peaked at $31K in Q4 2013. 12 funds tracked by Wall St. Rank hold GRCE as of Q1 2014.

E.E. Geduld reported no remaining Grace Therapeutics position as of Q1 2014 after selling out during the quarter.
E.E. Geduld sold 52 Grace Therapeutics shares in Q1 2014, an estimated $31K.
E.E. Geduld first reported a position in Grace Therapeutics in Q4 2013 and held it in 1 quarter.
E.E. Geduld's Grace Therapeutics position peaked at $31K in Q4 2013.
12 funds tracked by Wall St. Rank held Grace Therapeutics as of Q1 2014.

Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.